Online Program

Healthy People 2020: Laying the foundation for addressing social determinants of health and health equity

Tuesday, November 3, 2015 : 8:30 a.m. - 8:50 a.m.

Carter Blakey, US Department of Health and Human Services, Office of Disease Prevention and Health Promotion, Rockville, MD
Now in its fourth decade, the Healthy People initiative for the first time includes a specific overarching goal to create social and physical environments that promote good health for all, a dedicated Topic Area that defines the social determinants of health approach and establishes national objectives, and a Leading Health Indicator for social determinants.   Healthy People 2020 has placed an intentional, elevated focus on social determinants by emphasizing the need to move beyond controlling disease to address root causes of disease. This presentation will describe the key elements of Healthy People 2020’s social determinants approach that provide a solid foundation on which to structure policies and programs at various levels across multiple sectors aimed at improving health and quality of life for all populations.

Learning Areas:

Assessment of individual and community needs for health education
Chronic disease management and prevention
Diversity and culture
Implementation of health education strategies, interventions and programs
Program planning
Public health or related public policy

Learning Objectives:
Describe how the Healthy People 2020 social determinants of health framework can be applied in community and organizational health improvement plans and activities.

Keyword(s): Healthy People 2020, Health Promotion and Education

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Deputy Director of the HHS Office of Disease Prevention and Health Promotion and oversee and manage the Healthy People 2020 initiative.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.